STA-9090(Ganetespib) in Metastatic Ocular Melanoma

Clinical trial NCT01200238 · COMPLETED

Trial details

NCT number: NCT01200238
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ocular Melanoma

Start date: 2010-09-17
Primary completion: 2014-10-12
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.